Disrupted STIL-BRCA1 axis causes centrosome amplification and genomic instability.

Area of Science:

• Cell Biology
• Genetics
• Cancer Research

Background:

• Centrosome abnormalities are linked to chromosome segregation errors and genomic instability.
• STIL is a centrosome protein implicated in cell division regulation.

Purpose of the Study:

• To investigate the role of a cancer-associated STIL mutation (S76L) in centrosome abnormalities and DNA damage.
• To elucidate the STIL-BRCA1 interaction and its implications in cancer.

Main Methods:

• Identified and characterized a heterozygous missense mutation (S76L) in the STIL gene.
• Utilized overexpression systems to mimic the heterozygous state and assess protein localization and kinase activity.
• Evaluated DNA damage response and spindle organization in cells with STIL mutations.

Main Results:

• The STIL S76L mutation promotes centrosome amplification and DNA damage by disrupting the STIL-BRCA1 interaction.
• Mutant STIL causes BRCA1 mislocalization from the nucleus to centrosomes, increasing Aurora-A and PLK1 activity.
• Despite amplified centrosomes, cancer cells utilize HSET (KIFC1) for spindle organization, a survival mechanism.

Conclusions:

• A novel STIL-BRCA1 regulatory axis is identified, crucial for maintaining centrosome homeostasis and genome integrity.
• Disruption of this axis by the STIL S76L mutation contributes to cancer development.
• Targeting the HSET-dependent survival mechanism in mutant cells presents a potential therapeutic strategy.